[Form 4] Klaviyo, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Stephen Eric Rowland, President and officer of Klaviyo, Inc. (KVYO), reported voluntary sales of Series A common stock on 09/15/2025 under a Rule 10b5-1 trading plan adopted on 11/22/2024. The filing shows two disposal entries: 6,905 shares sold at a weighted-average price of $31.90 per share (transactions ranged $31.43–$32.27), and 200 shares sold at $31.24. After these sales the reported beneficial ownership is shown as 438,821 and 438,621 shares respectively. The filing discloses that the total reported holdings consist of 129,070 issued shares and 309,551 unvested restricted stock units convertible into common shares upon vesting.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating the transactions were preplanned and intended to provide affirmative defense under insider trading rules
- Filing discloses composition of holdings (129,070 issued shares and 309,551 unvested RSUs), improving transparency about economic ownership
Negative
- Insider disposal of 7,105 shares by the company President, which investors may view as insider selling
- Weighted-average sale price disclosure only; detailed per-trade quantities by price are not listed in the filing (though the filer offers to provide them on request)
Insights
TL;DR: Insider sold a small portion of holdings via a pre-established 10b5-1 plan; transaction is routine and non-material to outstanding shares.
The reported disposals total 7,105 Series A shares executed on 09/15/2025 under a Rule 10b5-1 plan adopted on 11/22/2024. The seller is the company President, which is material to note for governance transparency, but the filing does not indicate any change in role or unexpected event. The sales were executed across multiple prices with a disclosed weighted-average price and the filer committed to provide breakdowns on request, which supports transparency. No derivative transactions or amendments are reported.
TL;DR: Use of a 10b5-1 plan signals preplanned, compliant selling; the disclosure is routine but relevant to monitoring insider behavior.
The reporting person used a documented 10b5-1 trading plan, reducing the likelihood that these sales reflect undisclosed, company-specific developments. The filing clearly states the composition of remaining holdings (issued shares plus unvested RSUs), aiding assessment of true economic ownership. There is no indication of accelerated vesting, option exercises, or other atypical compensation events in this Form 4.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Series A Common Stock | 6,905 | $31.90 | $220K |
| Sale | Series A Common Stock | 200 | $31.24 | $6K |
Footnotes (1)
- These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 22, 2024. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.43 to $32.27 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Consists of (i) 129,070 shares of the Issuer's Series A Common Stock, par value $0.001 per share ("Series A Common Stock"), and (ii) 309,551 unvested restricted stock units awarded under the Issuer's 2023 Stock Option and Incentive Plan, each representing the contingent right to receive one share of Series A Common Stock upon vesting and settlement.
